1 Chemokine expression and function was monitored in an experimental model of granulomatous tissue formation after injection of croton oil in complete Freund's adjuvant (CO/CFA) into mouse dorsal air-pouches up to 28 days. 2 In the ®rst week, mast cell degranulation and leukocyte in¯ux (mononuclear cell, MNC, and polymorphonuclear cell, PMN) were associated with CXCR2, KC and macrophage in¯ammatory protein (MIP)-2 mRNA expression, as determined by TaqMan 1 reverse transcriptase-polymerase chain reaction. KC (*400 pg mg protein
Introduction
The initial phases of the host in¯ammatory response are characterized by the synthesis and release of several soluble mediators both peptidic and non-peptidic in nature. In particular, multi-potent cytokines such as interferon-g, interleukin (IL)-1, IL-4 or tumour necrosis factor (TNF)-a activate cells adjacent to the site of injury, including resident leukocytes (macrophages and mast cells), endothelial cells and interstitial ®broblasts (Smith et al., 1997; Paul & Seder, 1994) . Chemotactic factors are then generated to promote extravasation of blood-borne leukocytes (Gao et al., 1997; Luster, 1998) . Amongst the latter group of mediators, an important role is occupied by chemokines.
Chemokines are low molecular weight proteins classi®ed according to the presence or absence of an amino acid between the ®rst two cysteines, yielding CXC chemokines and CC chemokines (Baggiolini, 1998) , or CXCL and CCL chemokines according to a more recent nomenclature (Zlotnik & Yoshie, 2000) . CXC chemokines act predominantly on neutrophils and T lymphocytes, whereas CC chemokines are able to chemoattract monocytes, T lymphocytes, eosinophils, basophils, dendritic cells and NK cells, depending on the speci®c protein (Mantovani, 1999) . In the mouse, examples of CXC chemokines are KC (CXCL1) and macrophage in¯ammatory protein (MIP)-2 (CXCL2), whereas monocyte chemoattractant protein (MCP)-1 (or CCL2), , regulated on activated normal T cell expressed and secreted (RANTES or CCL5) andchemokine sub-groups is maintained also with respect to the receptor(s) they activate on target cells. CXCR are activated by CXC chemokines with a certain degree of promiscuity. CCR also share more than one chemokine (Premack & Schall, 1996; Zlotnik & Yoshie, 2000) . For instance, CXCR2 can be activated by KC, MIP-2 or LPS-induced CXC chemokine (LIX or CXCL5), whereas CCR5 binds MIP-1b (CCL4) and RANTES with comparable anities (Premack & Schall, 1996; Murphy et al., 2000) .
The speci®city of chemokine actions suggests a key role in the co-ordination of a range of in¯ammatory responses. The expression and biological actions of a given chemokine provides a rationale for the predominance of distinct leukocyte subsets in dierent in¯ammatory pathologies and the development of selective chemokine receptor antagonists is a rational approach for the discovery of novel anti-in¯ammatory molecules (Murphy et al., 2000) . This line of research may lead to novel therapies for asthma, characterized by eosinophil in¯ux, as well as rheumatoid arthritis, where neutrophil in¯ux into the aected joint occurs during the acute phases of the disease Ward, 1997) .
Few studies have investigated chemokine roles in long term models of chronic in¯ammation. For instance, the expression of MIP-2 and MIP-1a in a murine model of arthritis has been reported to be associated with development of the disease (Kasama et al., 1995) . A more recent study has investigated the time-dependency of mRNA expression for several chemokines in the model of collagen-induced arthritis (Thornton et al., 1999) . In a separate study, MCP-1 has been shown to have a central role in models of lung granuloma, with a preference towards those driven by a Th2 lymphocyte response (Chensue et al., 1996) .
In the present study we have used a model of murine granulomatous in¯ammation. Injection of a mixture of croton oil in complete Freund's adjuvant (CO/CFA) into a preformed dorsal air-pouch induces an intense in¯ammatory reaction associated with granuloma formation (Kimura et al., 1985; 1986) . A putative`in¯ammatory phase' characterized by neutrophil in¯ux and expression of pro-in¯ammatory cytokines such as IL-1a, IL-1b and tumour necrosis factor-a occurs within the ®rst week of in¯ammation (Appleton et al., 1993) . This is followed by a putative`repair phase' characterized by expression of anti-in¯ammatory cytokines (e.g. transforming growth factor-b) and occurs from day 14 onwards (Appleton et al., 1993) . We have used this model to investigate the expression of selected CXC and CC chemokines and chemokine receptors, at the level of transcription and translation, together with quanti®cation of the recruitment of distinct cell types during the dierent stages of the in¯ammatory reaction. A neutralizing strategy has been used to address the speci®c role that the chemokine MIP-1a and MCP-1 may be playing in the context of this complex in¯ammatory reaction.
A succinct account of this work has been presented at two recent meetings of the British Pharmacological Society (Carollo et al., 1999; .
Methods

Animals
Female Swiss Albino mice (28 ± 30 g body weight) were purchased from Banton and Kingsman (Hull, U.K.) and maintained on a standard chow pellet diet with tap water ad libitum. Animals were grouped at eight per cage in a room with controlled lighting (lights on 0800 h, o 2000 h) and temperature (21 ± 238C), and used 2 ± 3 days after their arrival. Animal work was performed according to Home Oce regulations (guidance on the operation of the Animals, (Scienti®c Procedures) Act 1986, United Kingdom).
Chronic granulomatous inflammation
The granulomatous air-pouch model was performed as described in the studies by Kimura et al. (1995; 1986) and Appleton et al. (1993) . Brie¯y, air pouches were formed by sub-cutaneous (s.c.) injection of 3 ml of air into the dorsal subcutaneous tissue. After 24 h (day 0), in¯ammation was induced by injection of 0.5 ml of 0.1% v v 71 croton oil in complete Freund's adjuvant containing 5 mg ml 71 Mycobacterium tuberculosis (CO/CFA) (Sigma-Aldrich Company Ltd, Poole, Dorset, U.K.) (Kimura et al., 1985; 1986; Appleton et al., 1993; Colville-Nash et al., 1995) . In some cases, 0.5 ml of incomplete Freund's adjuvant (IFA) alone were injected (Sigma-Aldrich) as a negative control group. A group of untreated animals was also added. At several days post-injection (days 3, 7, 14, 21, and 28), animals were sacri®ced by CO 2 exposure and the whole airpouches removed. The upper part of the granuloma was dissected together with the skin and used for histology (see below). The lower part of the granuloma was divided into three fragments, snap frozen and stored at 7808C prior to biochemical determinations (see below). In a few cases, the whole lower part of the granuloma was collected and its wet weight determined. Previous studies have demonstrated that the biochemical and histological characteristics of the upper and lower parts of the granuloma are identical (Appleton et al., 1993) .
Preparation and analysis of tissue sections by histology
The skin and granuloma samples (upper part) were divided into three portions and ®xed with dierent procedures speci®c for cryostat, paran or historesin sections.
Cryostat sections Tissues were snap-frozen in cold isopentane (BDH Laboratory Supplies, Poole, Dorset, U.K.), ®xed in O.C.T. compound (BDH Laboratory Supplies), and 10 mm sections cut in a cryostat, mounted on 3-aminopropyltriethoxy-silane coated slides (BDH Laboratory Supplies) and stored at room temperature.
Paran sections Tissue samples were ®xed in 3% paraformaldehyde and 0.5% glutaraldehyde (TAAB Laboratories, Aldermaston, Berkshire, U.K.) in sodium cacodylate buer (pH 7.4) for 24 h. Tissues were embedded in paran and 3 mm sections cut on an ultramicrotome (Reichert Ultracut; Leica, Austria), thereafter dewaxed with xylene and rehydrated through graded concentrations of ethanol.
Historesin sections Following ®xation in 3% paraformaldehyde and 0.5% glutaraldehyde (TAAB Laboratories), in sodium cacodylate buer (pH 7.4) for 24 h, and embedding in historesin (Technovit 7200, Unicryl TM , TAAB Laboratories), 1.5 mm sections were made and stained with May-Grumwald (1 : 2) and Giemsa (1 : 10) (BDH Laboratory Supplies).
Immunohistochemistry
Cryostat and paran sections were ®xed in acetone and rehydrated in 10 mM phosphate-buered saline (PBS, pH 6.0). Endogenous peroxidases were quenched with 1% H 2 O 2 (30% v v 71 ) in methanol, prior to blocking non-speci®c binding with normal goat serum (Vectastain 1 ABC Kit, Vector Laboratories, Bretton, Peterbourough, U.K.) diluted 1 : 50 in PBS supplemented with 0.1% BSA (Sigma-Aldrich). Sections were incubated overnight at 48C with a polyclonal rabbit anti-mouse MIP-1a (®nal dilution of 1 : 2000) or a polyclonal rabbit anti-mouse MCP-1 (®nal dilution of 1 : 1000), respectively. Both antibodies have been produced at the University of Michigan Medical School, and have been previously used to monitor the expression of these chemokines in murine models of in¯ammation (Chensue et al., 1996; DiPietro et al., 1998; Kunkel et al., 1996; Standiford et al., 1995) . A non-immune rabbit serum (Sigma-Aldrich) was used as a negative control. Another control was represented by the anti-MCP-1 serum pre-absorbed (24 h, 48C) with 1 mg mouse MCP-1 (R&D Systems, Abingdon, Oxon, U.K.). In all cases, tissues were counter-stained with 0.25% toluidine blue in 0.25% Michaelis' veronal acetate-hydrochloric acid buer (pH 4.5) or Harris' haematoxylin (BDH Laboratory Supplies). Sections were air-dried and mounted in DPX (BDH Laboratory Supplies) prior to observation by light microscopy using an Olympus BH-2-RFCA microscope. The anti-MIP-1a antibody did not react with paran sections, whereas the anti-MCP-1 antibody reacted with both cryostat and paran sections.
Semi-quantitative analysis of cell influx by histology
Historesin sections were used for morphological analysis of tissues obtained from IFA treatment and to determine cell number in granuloma tissues (after injection of CO/CFA) throughout the entire time course. Using a high power objective (magni®cation, 6600) cells were counted in three areas of approximately 100 mm 2 , using ®ve distinct serial sections (15 mm of space between each section) for two dierent animals by an observer unaware of the treatments. The degree of PMN (590% neutrophils) and MNC (lymphocytes and monocytes/macrophages) in®ltration as well as the presence of mast cells (intact or degranulated) were determined in the dierent areas of the skin and in the granuloma. The number of ®broblasts was also monitored. Data are reported as number of cells per 1006100 mm 2 of tissue area.
Biochemical determinations
Detection of chemokine levels by ELISA Samples were placed in lysing buer (1% P-40 Nonidet, 500 mM NaCl, 50 mM HEPES, 20 mg/ml leupeptin) (Standiford et al., 1995) at an approximate ratio of 10 mg ml 71 and homogenized using a T25 IKA Labortechnik homogenizer (Staufen, Munich, Germany). Chemokine levels were measured in tissue supernatants using commercially available ELISA kits for mouse MIP-1a, MIP-2, KC and RANTES (R&D Systems, Abingdon, Oxon, U.K.) and MCP-1 (Biosource International, Camarillo, CA, U.S.A.).
Enzymatic activities Myeloperoxidase (MPO) and N-acetylb-D-glucosaminidase (NAG) activity in tissue supernatants were determined as an indirect measurement of neutrophil and monocyte in¯ux (Bailey et al., 1982; Mullane et al., 1985) .
The MPO reaction was performed in 200 ml total volume using 2 mM 3,3',5,5'-tetramethyl-benzidine (Sigma-Aldrich) in 50 mM acetate buer (pH 6) as a substrate, and hydrogen peroxide (20 ml of a solution 30% v v 71 ). After 30 min at room temperature, absorbance was read at 620 nm wavelength and interpolated on a standard curve constructed with 0 ± 2000 mu l 71 human neutrophil MPO (Calbiochem, Beeston, Nottingham, U.K.). Data are expressed as mu mg protein 71 . The NAG reaction was performed in 250 ml total volume containing unknown sample and the substrate p-nitrophenyl-N-acetyl-b-D-glucosaminide (2.5 mM in 50 mM citrate buer, pH, 4.5) (Sigma-Aldrich). After 45 min incubation at 378C, the reaction was initiated by adding 100 ml of glycine buer (0.2 M, pH 10.4; BDH Laboratory Supplies). Readings at 405 nm wavelength were interpolated on a standard curve constructed with p-nitrophenol (0 ± 500 nmol ml 
TaqMan 1 reverse-transcriptase-polymerase chain reaction (RT ± PCR) analysis
TaqMan real-time RT ± PCR assay allows reliable, reproducible and accurate measurement of mRNA expression following activation of a given gene (Gibson et al., 1996; Heid et al., 1996; Hirayama et al., 1998; Lie & Petropoulos, 1998; Orlando et al., 1998) . Here, this technique was applied to monitor chemokine and chemokine receptor expression. Total RNA was extracted from pooled samples of skin or granuloma tissue (n=5 ± 10), following homogenization with a T25IKA Labortechnik homogenizer pre-sterilized in a bath of Trigene 1 solution (2%) overnight. To avoid contamination, the homogenizer was cleaned with ethanol, Trigene 1 solution and sterile water between each tissue sample. The RNA yield and purity was determined by the A 260 /A 280 ratio and the integrity of total RNA extracted was con®rmed by the presence of 28S and 18S bands following electrophoresis on a 1% agarose gel. RNA was further puri®ed by selective precipitation, using RNeasy 1 mini-spin columns (QIAGEN, Crawley, West Sussex, U.K.) and stored at 7808C until use. cDNA was synthesized using Superscript II kit (GIBCO-BRL, Life Technologies Ltd, Paisley, Scotland, U.K.), with 2 mg of total RNA being converted into cDNA by addition of 1 ml of Superscript II reverse transcriptase (RTEnzyme 1 , 10,000 ± 50,000 units ml 71 ) (GIBCO-BRL). Negative controls were obtained by reverse transcriptase omission. A standard curve to calculate relative amounts of transcript in unknown samples was constructed using cDNA generated from the lymph nodes of oxazolone-treated mice.
TaqMan 1¯u orogenic probes used were -FAM (6-carboxiuorescein; emission 1538 nm) or -JOE (6-carboxy-4,5-dichloro-2,7-dimethoxy¯uorescein; emission 1546 nm) reporter and TAMRA (6-carboxytetramethylrodamine; emission 1582 nm) quencher dyes (Applied Biosystems, Foster City, CA, U.S.A.). Primers and probes were designed in accordance to the`guidelines for designing TaqMan 1 uorogenic probes for 5' nuclease assay' (provided by Perkin Elmer Applied Biosystems). Primers were obtained from Genosys (Sigma-Genosys Ltd, Pampisford, Cambridgeshire, U.K.) and optimized using a standard cDNA template. Table  1 summarizes the sequences of the probes and primers used. TaqMan 1 reactions were set up as indicated by the manufacturers and ampli®ed using the ABI PRISM 7700 Sequence Detection System. cDNA prepared from granuloma samples was diluted 1/10 and tested in duplicate or triplicate in the TaqMan 1 RT ± PCR assay. Primers and probes were also designed for MIP-1a and CCR1 and tested without success.
For each well a mixture of forward and reverse primers, probes and TaqMan 1 Master Mix (AmpliTaq Gold DNA Polymerase, AmpErase UNG, dNTPs with dUTP) (GIBCO BRL) was added (see Table 2 for the optimal ratios). Cycling conditions for the TaqMan 1 PCR reactions were as follows: 2 min at 508C, 10 min denaturation at 958C, 15 s annealing at 958C and 1 min extension at 608C. For data handling, a standard curve was constructed from a scatter plot of log dilution factor vs the corresponding threshold cycle (C T ) and used to calculate the relative abundance of each target gene in each sample. 18S C T values were used to correct for the amount of cDNA in each sample and give a normalized relative amount for each sample.
Treatment with neutralizing antisera
The same antisera used for immunocytochemistry of MIP-1a and MCP-1 were also used for assessing the function in vivo that either chemokine might have. Both rabbit sera have been validated for the respective chemokine in vitro and in vivo assays (Chensue et al., 1996; DiPietro et al., 1998; Standiford et al., 1995) .
The anti-MIP-1a rabbit serum, or non-immune rabbit serum (Sigma-Aldrich), were given i.p. at the dose of 0.5 ml per mouse (Di Pietro et al., 1998) per injection on days 71, +1 and +4, with CO/CFA being injected into the air-pouch at day 0. Animals were sacri®ced at days 7 or 21, since these times corresponded approximately to the peaks of the MIP1a and MCP-1 protein levels.
The anti-MCP-1 rabbit serum has been used shown to be active in a murine model of lethal endotoxemia (Zisman et al., 1997) . Its activity has also been shown in a model of granuloma formation in which repeated injections decreased the size of the granuloma by about the 30% (Chensue et al., 1996) . Since the peak of MCP-1 occurred at day 21, the antibody, or non-immune rabbit serum, were given i.p. at the dose of 0.5 ml per mouse on days 10 and 14, and animals sacri®ced on day 21.
In both cases a series of biochemical determinations in the granuloma samples was made.
Statistics
Dierences among groups were analysed using ANOVA plus Bonferroni test taking a P value 50.05 as signi®cant. Non- 
Results
CO/CFA, but not IFA, injection provokes granuloma formation CO/CFA injection produced formation of granulomatous tissue already detectable at day 3. The tissue wet weight increased in a time dependent manner until day 7, decreasing thereafter ( Figure 1 ). In contrast, IFA injection did not produce formation of granuloma, and the weight of the tissue did not signi®cantly change throughout the entire time course. These dierences were con®rmed by histology. IFA caused only a large increase in the thickness of the adipose tissue ( Figure 2A illustrates the morphology at day 14) when compared to the skin of control mice ( Figure 2B ). CO/CFA produced a series of time-dependent changes illustrated from Figure 2C to G. On day 3, the presence of the granulomatous tissue under the skeletal muscle layer was detected ( Figure  2C ). The thickness of the granuloma doubled by day 7 ( Figure 2D) , with a similar appearance at day 14 ( Figure 2E) . A contraction of the granulomatous tissue, replaced by ®brotic tissue mainly formed by collagen, was observed on day 21 ( Figure 2F) . A similar pattern was observed at day 28 ( Figure 2G ).
The majority of the cells in the granuloma were PMN and MNC. Fibroblasts could also be seen, whereas mast cells were predominantly found in the skin layers. The localization and the numbers of the dierent cells varied throughout the time-course (Figure 3 ). An increase in MNC was observed by day 7 in the granulomatous layer, decreasing by days 14 to 21, thereafter increasing again at day 28 ( Figure 3D ). The same pro®le was detected in the adipose tissue ( Figure 3B ), but not in the dermis and in the skeletal muscle layer, where MNC in®ltration decreased from day 7 onwards (Figure 3A,C) . Similar changes were detected in PMN in¯ux throughout the tissue layers: following a peak at day 7 and a timedependent reduction by day 21, a second phase of in¯ux into the granulomatous and adipose tissue layers was apparent at day 28 (Figure 3) . However, the changes in the granuloma were more pronounced with PMN and MNC counts, 5 ± 10-fold higher than those counted in the skin layers. An approximate 2 ± 3-fold increase in mast cell numbers was measured in all tissue layers by days 7 and 14 post-in¯ammation, 50% of which were degranulated (data not shown). Detection of cells became dicult by day 21 in the skeletal muscle tissue probably because of Shown are the concentrations of probes and primers and the optimal ratios, in relation to C T values, as used for TaqMan 1 analysis. Figure 1 Time-course of granuloma weight after CO/CFA or IFA injection into murine air-pouches. Change in the weight of in¯amed tissue after local injection of 0.5 ml IFA or CO/CFA mixture. Note that granuloma formation occurs only after CO/CFA injection (see Figure 2 ). Data are mean+s.e.mean of eight mice per group. *P50.05 vs day-3 group.
the replacement of this tissue with the ®brotic ®bres 
Enzymatic activities in the granuloma
MPO activity increased rapidly (*30 mu mg protein 71 per day) up to day 7 post-CO/CFA injection ( Figure 4A ). In line with histological quanti®cation, lower MPO values were measured at days 14 and 21, with a subsequent increase at day 28 ( Figure 4A ). High MPO values clearly corresponded to PMN in®ltration, as seen in Figure 4C . NAG activity followed a dierent pro®le, with values above skin controls from day 7, and a time-dependent increase up to the fourth week of in¯ammation ( Figure 4B ). The majority of MNC had migrated by day 28 as determined by morphology ( Figure 4D ). However, PMN were also present at this time-point (data not shown).
Chemokines and chemokine receptors in the granuloma
The mRNA expression of CXCR2 showed a single peak maximal at day 3. Relatively high amounts of this mRNA were also detected at day 7, after which values decreased rapidly towards control ( Figure 5A ). Of the three potential CXCR2 Figure 3 Semi-quantitative analysis of cell population in the dierent skin layers and granulomatous tissue during CO/CFA induced in¯ammation. Tissues (skin or granuloma) were embedded in historesin, stained and analysed as described in Methods. Analysis could distinguish between mast cells, MNC, PMN and ®broblasts present in the dermis (A), adipose tissue (B), skeletal muscle tissue (C) and granulomatous tissue (D). Values represent mean+s.e.mean of cell number counted in three dierent regions of 1006100 mm 2 area, ®ve distinct serial sections (1.5 mm) of four dierent mice.
ligands tested, KC (CXCL1) and MIP-2, but not LIX (CXCL5), mRNA were detected and found to be maximal at day 3, in correspondence to the CXCR2 mRNA ( Figure 5B ). The pro®le of CCR2 and CCR5 mRNA expression was less clear, and changes were less pronounced ( Figure 5C ,E). The mRNA for some putative ligands for these receptors was also increased, though with some dierences. Figure 5D shows MCP-1 (CCL2) mRNA being high at days 3 and 28, whereas MCP-3 (CCL 7) mRNA highest values are measured at days 14 and 28. MIP-1b (CCL4) and RANTES (CCL5) follow a similar pattern of expression, with MIP-1û mRNA being clearly highly expressed during the ®rst week of in¯ammation ( Figure 5F ).
Chemokine protein expression within the granulomatous tissue paralleled the detection of mRNA. KC (CXCL1) and MIP-2 protein were clearly elevated within the ®rst week of in¯ammation as detected by ELISA ( Figure 6A ). MIP-1a (CCL3) was maximally expressed at day 3 ( Figure 6B ), whereas MCP-1 (CCL2) levels increased in a time-dependent fashion, with values above control skin samples at day 21 ( Figure 6C ). RANTES (CCL5) protein expression increased gradually in a timedependent fashion with maximal values at day 28 ( Figure 6D ).
Immunohistochemistry for MIP-1a and MCP-1
The cell source of two chemokines that were expressed at dierent stages of this experimental in¯ammatory reaction was then investigated. In the granulomatous tissue of samples collected at day 7 post CO/CFA injection, MIP-1a immunoreactivity was detected in ®broblasts ( Figure 7A ) and MNC ( Figure 7B ). After the ®rst week of in¯ammation, the number of positive cells decreased in accordance with the data obtained by ELISA (data not shown). MCP-1 localization was studied in correspondence of the peak of protein expression, i.e. at day 21 ( Figure 6C ). A part from some scattered MNC and ®broblasts ( Figure 7E ), MCP-1 immuno-reactivity was predominantly associated with mast cells (Figure 7D,F) . The identity of this cell type was also con®rmed by counter-staining with toluidine blue (data not shown). No staining was visualized in sections stained with pre-adsorbed antibody ( Figure 7C ).
Effect of neutralizing antisera to MIP-1a and MCP-1
Treatment of mice with the anti-MIP-1a serum did not signi®cantly modi®ed the in¯ammatory response as measured at day 7, with the exception of a reduction in MIP-1a contents (Table 3 ). In contrast, animals treated with the anti-MIP-1a serum displayed higher values for in¯ammatory parameters at day 21, namely for MPO activity, NAG activity and MCP-1 contents (Table 3) .
The anti-MCP-1 serum was tested only at day 21, since this time-point corresponded to the peak of endogenous MCP-1 expression (see Figure 6c) . Table 4 shows the data obtained, with a signi®cant decrease (*40%) in NAG activity and a reduction in the content of RANTES. This was associated with a signi®cant increase in MPO values (Table 4) .
Discussion
The granulomatous air-pouch has been previously employed to study the pro®le of expression of pro-in¯ammatory and anti-in¯ammatory cytokines, mainly using an immunohistochemistry strategy (Appleton et al., 1993) . The interest in this model stems from the morphological analogies between the experimental granuloma and the pannus observed in the joints of patients aected by rheumatoid arthritis, for instance presence of resident macrophages and ®broblasts (Kimura et al., 1985; 1986; Kasama et al., 1995) . Injection of CO/CFA initiates a complex in¯ammatory reaction. Based on distinct patterns of expression, and on the appearance of PMN and MNC into the granuloma, the existence of an 4286+745 (6) 5187+316 (5) Animals were treated with the mixture of CO/CFA at day 0, and with non-immune rabbit serum or with the anti-MIP-1a antiserum at days 71, 1 and 4 (500 ml i.p. each time). Tissues were collected either at day 7 or day 21, and the dierent markers of in¯ammation determined as described in Methods. Values shown are the mean value+s.e.mean of (n) mice per group. *P50.05 vs corresponding value in the non-immune serum group. (5) Animals were treated with the mixture of CO/CFA at day 0, and with non-immune rabbit serum or with the anti-MCP-1 antiserum at days 10 and 14 (0.5 ml i.p. each time). Tissues were collected either at day 7 or day 21, and the dierent markers of in¯ammation determined as described in Methods. Values shown are the mean value+s.e.mean of (n) mice per group. * P50.05 vs corresponding value in the non-immune serum group.
acute phase (maximal within the ®rst week) and of repair phase (from day 21 onwards) has been proposed (Appleton et al., 1993) . Initially, we validated the model. We could demonstrate the presence of layers of granulomatous tissue from day 3, with a time-dependent progressive thickening. Day 7 corresponded to the time-point of maximal PMN in®ltration and the presence of characteristic signs of an intense in¯ammatory reaction, including mast cell degranulation. It has been demonstrated that this stage presents a high incidence of neo-vessel formation (angiogenesis) (ColvilleNash et al., 1995) . These events occur also at the skin level, with leukocyte in®ltration into the derma and hypoderma. However, quantitatively, the major portion (480%) of blood-borne cells migrated into the granuloma.
The existence of a PMN in¯ux within the ®rst week was con®rmed by measurement of MPO activity. Assessment of this enzyme has often been used to determine tissue in®ltration by PMN (Mullane et al., 1985) . MPO measurement coupled to histology and the expression of PMN selective chemokines (see below) suggest that the ®rst week of this in¯ammatory reaction was predominantly characterized by PMN accumulation. The striking expression of CXCR2 in the granuloma at days 3 and 7 con®rms this suggestion, since PMN express high levels of this receptor (Murphy et al., 1996) . CXCR2 mRNA expression was paralleled by expression of its ligands both at the mRNA and protein level. In particular, MIP-2 and KC were strongly expressed within the ®rst week of in¯ammation, whereas the recently discovered CXC chemokine LIX was not. Dierences in time expression of these three chemokines have been reported during experimental endotoxemia (Rovai et al., 1998) , but are unlikely to explain the lack of detection of LIX mRNA in this model. A few days of delay were observed in terms of peak of mRNA and protein expression for MIP-2 and KC: this is not surprising and may indicate the existence of mechanism(s) for controlling mRNA translation. We have observed a similar feature for granuloma expression of the anti-in¯ammatory protein annexin-1 (unpublished data). A human analogue of the CXC murine chemokine KC (likely to be gro-a; Zlotnik & Yoshie, 2000) is detected in synovial¯uids of patients aected by rheumatoid arthritis, with synovial ®broblasts being the major cell source (Koch et al., 1995) : it is possible that KC-related chemokines play a functional role in attracting human PMN into the injured joints.
A dierence in the time course of expression between the two CC chemokines MIP-1a and MCP-1 was observed in this model of chronic in¯ammation. MIP-1 a seems to play an important role in human rheumatoid arthritis (Koch et al., 1995) , and its mRNA is abundantly expressed in the joints during mouse collagen-induced arthritis (Kasama et al., 1995; Kunkel et al., 1996) . This CC chemokine acts as a chemoattractant on both PMN and MNC (DiPietro et al., 1998; Ajuebor et al., 1999) , however the pro®le of expression in this model indicates a major eect upon the PMN. In addition, MIP-1a activates mast cells (Alam et al., 1992) and therefore may contribute to the degranulation of this cell type observed from day 3 post-CO/CFA injection. In view of the pivotal role that mast cell-derived products play in the recruitment of PMN (Granger & Kubes, 1994) , it is tempting to propose a model in which MIP-1a plays central role in the ®rst week of in¯ammation (the so-called`acute phase' of Appleton et al., 1993) . Other chemokines such as KC may also have a prominent role in producing mast cell activation (Harris et al., 1996) . The neutralization experiments however indicate that if MIP-1a plays a proin¯ammatory role within day 7, it is clear that its role can be taken over by other mediators or chemokines. The set of functional data indicates, rather, that early MIP-1a expression possesses an anti-in¯ammatory role on the progression of the granulomatous in¯ammation. It is of interest that MIP-1a expression has been associated with murine wound repair (DiPietro et al., 1998) .
MCP-1 expression was clearly associated with this latter phase characterized by deposition of collagen ®bres, ®bro-blast proliferation and ®brosis (Appleton et al., 1993; Colville-Nash et al., 1995) . The existence of mechanism(s) regulating mRNA translation, or the potential need for accessory factors, are likely to be involved for MCP-1 since a modest increase in MCP-1 mRNA was detected at day 3, but the protein was not detectable by ELISA. The second peak of MCP-1 mRNA was linked to the presence of MCP-1 protein, from day 14 onward. RANTES mRNA and protein followed a similar pro®le of expression.
At variance from the hypothesis of Appleton et al. (1993) , who proposed the existence of a process of resolution from day 14 onward, in our hands many parameters of in¯ammation were still elevated or present even at day 28. In fact, whereas low values were measured at day 21 for several parameters, including PMN and MPO activity, chemokine and chemokine receptor mRNA, clear signs of an active in¯ammatory response were measured at day 28: mast cell degranulation and PMN in®ltration were clearly seen in the granuloma. This was also associated to high MPO activity, besides the expected high value for NAG activity. It is now clear that monocytes also contain MPO positive granules, and therefore can contribute to tissue appearance of this enzymatic activity (Dallegri & Ottonello, 1997; Korthuis et al., 1994; Marquez & Dunford, 1997) . Therefore, in contrast to previous publications on this model of granuloma, we would propose the presence of a process of ®brosis characterizing the second phase of in¯ammation from day 14 onwards. Importantly, MCP-1 has been shown to be a potent pro-®brotic chemokine (Hogaboam et al., 1999) , whereas RANTES does not share this activity (Lloyd et al., 1997) . Together with a published study (Appleton et al., 1993) , we propose a ®brotic alteration of the granuloma driven initially by transforming growth factor-b (that peaks at day 14), and subsequently by MCP-1. In this scenario, RANTES may contribute in an as yet unknown manner to the chronicization of the in¯ammatory reaction, as recently shown in an experimental model of in¯ammatory bowel disease (Ajuebor et al., 2001) .
The experiment of neutralization supports, to our opinion, this hypothesis. The anti-MCP-1 antiserum reduced NAG activity and RANTES values, and elevated MPO activity, as measured at day 21. It may be proposed, then, that MCP-1 and possibly RANTES recruit monocyte/macrophages at this time-point. Importantly, NAG is expressed at higher levels by dierentiated macrophages (de Moulder et al., 1983) . The higher MPO values observed in the anti-MCP-1 group may indicate a lower degree of removal of migrated PMN caused by the lower number of macrophages.
Finally, the availability of two anti-sera validated for detection of MIP-1a and MCP-1 in tissues allowed us to monitor the cellular localization of these chemokines at the peak of their expression. Monocyte/macrophages and ®bro-blasts were positive for MIP-1a in the 7 day-granuloma. This ®nding is in agreement with other experimental models of in¯ammation (Chensue et al., 1996; di Pietro et al., 1998; Kunkel et al., 1989; Standiford et al., 1993) . MCP-1 was predominantly expressed by mast cells located in the granuloma as well as in the surrounding skin layers. We believe this is an important observation, and linked to other studies (Tailor et al., 1999) it suggests mast cells as a major source of CXC and CC chemokines in in¯ammation. With respect to this speci®c chemokine, we have recently found that mouse peritoneal mast cells are the major producers of MCP-1 during acute peritonitis (Ajuebor et al., 1999) . It therefore seems that mast cells have the capacity to synthesize several in¯ammatory mediators, including chemokines, and therefore have a prominent role in many forms of in¯ammation. Importantly, cell responsiveness to MCP-1 is altered during experimental chronic in¯ammation (Johnston et al., 1999) . If this phenomenon also occurs in our model of granulomatous air-pouch, then we propose that mast cell derived MCP-1 may be responsible for the delayed (421 days) neutrophil recruitment.
